by Steven A. Grossman | Mar 4, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. President Trump nominated Johns Hopkin Professor Martin Makary to be the next Commissioner of FDA. His confirmation hearing is Thursday, March 6 at 10...
by Steven A. Grossman | Feb 27, 2025 | Short Takes and Updates
LIVE EVENT!Come join us tomorrow, (Friday, February 28) at 11 a.m. ET to discuss the need for a regulatory pathway to enable the development of products that extend the span of life free of chronic diseases and...
by Steven A. Grossman | Feb 25, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. Never Lose the Whip CountToday (or this week’s) House vote on the reconciliation budget is likely to be one of the most momentous votes in my lifetime...
by Steven A. Grossman | Feb 23, 2025 | Short Takes and Updates
Information for Reporters[1] Note: Since the original column was published, I have become aware that lay-offs should not be referred to as a reduction-in-force (RIF) because that term triggers certain procedures and protections that employees might not have in the...
by Steven A. Grossman | Feb 20, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. FDA At Risk on Four FrontsAll the federal public health programs are under siege. While my focus is on FDA, I want readers to know that NIH and CDC...
by Steven A. Grossman | Feb 18, 2025 | Short Takes and Updates
FDA employees—public-spirited and committed—are the heart of the agency and can proudly point to a lengthy record of accomplishment. Our country has safe food and safe and effective medical products because of their efforts. We are all affected: every American uses...
